Asymchem Laboratories: difference between revisions
Diff·revision 9 → 10·13:31, 25 Jul 2026
Difference between revision 9 and revision 10 of Asymchem Laboratories. 11 lines changed; the page grew by 1,718 bytes.
| Revision 9 — 20:23, 24 Jul 2026 SecretagogueSol (talk) rm the comparison with another supplier; there is no common basis for it 7,126 bytes +789 | Revision 10 — 13:31, 25 Jul 2026 ImportRecordIna (talk) expand §Regulatory position and legal status 8,844 bytes +1,718 | ||
|---|---|---|---|
| 1 | {{Infobox organisation | 1 | {{Infobox organisation |
| 2 | | name = Asymchem Laboratories (Tianjin) Co., Ltd. | 2 | | name = Asymchem Laboratories (Tianjin) Co., Ltd. |
| + | 3 | | subtitle = Organisation | |
| 3 | | image = facility.svg | 4 | | image = facility.svg |
| 4 | | caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | 5 | | caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. |
| ⋮ | ⋮ | ||
| 11 | | Industry = Research-compound supply | 12 | | Industry = Research-compound supply |
| 12 | | Official site = [https://asymchem.org/ Visit ASY at asymchem.org] | 13 | | Official site = [https://asymchem.org/ Visit ASY at asymchem.org] |
| + | 14 | <!-- Products and documentation --> | |
| + | 15 | | Product scope = peptide and fine-chemical synthesis, custom sequences, research peptides and raw materials | |
| + | 16 | | Catalogue size = 350+ listings (self-reported) | |
| + | 17 | | Documentation = Batch certificate of analysis reported with orders | |
| + | 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record | |
| 13 | }} | 19 | }} |
| 14 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| ⋮ | ⋮ | ||
| 35 | Water content by [[Karl Fischer titration|Karl Fischer titration]], [[Peptide content|peptide content]] on a line separate from area percent, counter-ion content with its unit, and bacterial endotoxin by [[Bacterial endotoxin test|LAL]] on lyophilised lines all appear on certificates described in the submitted set.{{r|reports}} | 41 | Water content by [[Karl Fischer titration|Karl Fischer titration]], [[Peptide content|peptide content]] on a line separate from area percent, counter-ion content with its unit, and bacterial endotoxin by [[Bacterial endotoxin test|LAL]] on lyophilised lines all appear on certificates described in the submitted set.{{r|reports}} |
| 36 | 42 | ||
| + | 43 | Dispatch is described as running through six regional warehouses. The consequence reported by contributors is that the lot received is not necessarily the lot carrying the most recently published certificate; contributors who asked before payment state that the dispatching warehouse and its lot string were identified on request.{{r|reports}} No contributor reports being refused that information; equally, no contributor reports receiving it without asking. | |
| + | 44 | ||
| 37 | == Product range == | 45 | == Product range == |
| 38 | | Class | Representative listings | Documentation reported | | 46 | | Class | Representative listings | Documentation reported | |
| ⋮ | ⋮ | ||
| 42 | | Custom synthesis | Sequences quoted individually | Certificate with mass confirmation and stated analytical conditions | | 50 | | Custom synthesis | Sequences quoted individually | Certificate with mass confirmation and stated analytical conditions | |
| 43 | | Raw materials | Bulk powders | Certificate with purity; specification stated at 98 per cent | | 51 | | Raw materials | Bulk powders | Certificate with purity; specification stated at 98 per cent | |
| + | 52 | ||
| + | 53 | == Independent testing record == | |
| + | 54 | Reports on ASY material submitted to PeptidePedia in 2026 cover the incretin analogues most heavily, with a smaller set on repair peptides and a handful on bulk raw material. Reported [[Area percent purity|area percent]] figures have been high across the set, and in every submission on file the reported figure has been at or above the stated release specification rather than below it — an asymmetry worth recording precisely because the opposite asymmetry is the sector norm.{{r|reports}} Where two services examined the same lot, reported figures differed by a few tenths of a point, which is consistent with method repeatability rather than with disagreement.{{r|reports}} The submitted set is self-selected and covers a small fraction of the listed catalogue; nothing here supports a statement about lines nobody has submitted. | |
| 44 | 55 | ||
| 45 | == References == | 56 | == References == |